TandemLife Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 65

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $244M

  • Investors
  • 1

TandemLife General Information

Description

Developer of cardiopulmonary bypass devices designed to treat short term heart failure. The company's cardiopulmonary bypass devices enables performing temporary, emergent cardiopulmonary bypass procedures with confidence, enabling healthcare professionals to improve patient outcomes and reduce healthcare costs.

Contact Information

Website
www.tandemlife.com
Formerly Known As
TandemHeart
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 240 Alpha Drive
  • Pittsburgh, PA 15238
  • United States
+1 (412)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Acquirer
LivaNova
Corporate Office
  • 240 Alpha Drive
  • Pittsburgh, PA 15238
  • United States
+1 (412)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TandemLife Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 04-Apr-2018 $244M Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Grant 04-Oct-2005 Completed Generating Revenue
2. Grant 17-May-2004 $110K $33M Completed Generating Revenue
1. Early Stage VC 08-Feb-2001 $33M $33M Completed Generating Revenue
To view TandemLife’s complete valuation and funding history, request access »

TandemLife Patents

  • 175

    Total Documents Applications and Grants

  • Total Patents Families

  • 107

    Granted

  • 46

    Pending

  • Expiring in next 12 mo

TandemLife Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250025632-A1 Purge syringe Pending 20-Jul-2023
EP-4494670-A1 Purge syringe Pending 20-Jul-2023
EP-4470576-A1 Oxygenator with improved blood mixing Pending 01-Jun-2023
EP-4473985-A1 Oxygenator with circumferentially constricting housing Pending 01-Jun-2023
US-20240399037-A1 Oxygenator with improved blood mixing Pending 01-Jun-2023 A61M1/1625
To view TandemLife’s complete patent history, request access »

TandemLife Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TandemLife Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advent Life Sciences Venture Capital Minority
Advent Venture Partners Venture Capital Minority
Aventic Partners PE/Buyout Minority
Credit Suisse Investment Bank Minority
Equity4Life Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

TandemLife FAQs

  • When was TandemLife founded?

    TandemLife was founded in 1996.

  • Where is TandemLife headquartered?

    TandemLife is headquartered in Pittsburgh, PA.

  • What is the size of TandemLife?

    TandemLife has 65 total employees.

  • What industry is TandemLife in?

    TandemLife’s primary industry is Surgical Devices.

  • Is TandemLife a private or public company?

    TandemLife is a Private company.

  • What is the current valuation of TandemLife?

    The current valuation of TandemLife is .

  • What is TandemLife’s current revenue?

    The current revenue for TandemLife is .

  • How much funding has TandemLife raised over time?

    TandemLife has raised $33M.

  • Who are TandemLife’s investors?

    Advent Life Sciences, Advent Venture Partners, Aventic Partners, Credit Suisse, and Equity4Life are 5 of 13 investors who have invested in TandemLife.

  • When was TandemLife acquired?

    TandemLife was acquired on 04-Apr-2018.

  • Who acquired TandemLife?

    TandemLife was acquired by LivaNova.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »